Neuraminidase inhibitor susceptibility of porcine H3N2 influenza A viruses isolated in Germany between 1982 and 1999

被引:13
|
作者
Bauer, Katja
Schrader, Christina
Suess, Jochen
Wutzler, Peter
Schmidtke, Michaela
机构
[1] Univ Jena, Ctr Med, Inst Virol & Antiviral Therapy, D-07740 Jena, Germany
[2] Fed Inst Risk Assessment, D-14195 Berlin, Germany
[3] Friedrich Loeffler Inst, D-07743 Jena, Germany
关键词
Porcine influenza; neuraminidase inhibitors; oseltamivir; zanamivir; phenotyping; genotyping; resistance;
D O I
10.1016/j.antiviral.2007.03.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
As an intermediate host of avian and human influenza A viruses (FLUAV) pigs may play a potential role in interspecies virus transmission and reassortment of viral genes including those conferring antiviral drug resistance. Porcine FLUAV isolated in Germany between 1989 and 2001 contains mutations in the M2 gene inducing amantadine resistance. No data exist on neuraminidase inhibitor (NAI) susceptibility of these porcine FLUAV. We studied the antiviral activity of NAI against seven selected H3N2 FLUAV isolated from pigs in Germany between 1982 and 1999. All isolates were susceptible towards oseltamivir and zanarnivir in neuraminidase enzyme-inhibition assays. Both compounds inhibited virus spreading and reduced the virus yields and plaque size at low concentrations. Higher concentrations were necessary to reduce the plaque number. Two isolates that differed in glycosylation pattern of viral hemagglutinin (HA) showed markedly reduced drug susceptibility in cell culture-based assays. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:219 / 226
页数:8
相关论文
共 50 条
  • [21] Rare Influenza A (H3N2) Variants with Reduced Sensitivity to Antiviral Drugs
    Dapat, Clyde
    Suzuki, Yasushi
    Saito, Reiko
    Kyaw, Yadanar
    Myint, Yi Yi
    Lin, Nay
    Oo, Htun Naing
    Oo, Khin Yi
    Win, Ne
    Naito, Makoto
    Hasegawa, Go
    Dapat, Isolde C.
    Zaraket, Hassan
    Baranovich, Tatiana
    Nishikawa, Makoto
    Saito, Takehiko
    Suzuki, Hiroshi
    EMERGING INFECTIOUS DISEASES, 2010, 16 (03) : 493 - 496
  • [22] Susceptibility of human H3N2 influenza virus to oseltamivir in South Korea, 2009-2011
    Park, Sehee
    Kim, Jin Il
    Lee, Ilseob
    Lee, Sangmoo
    Hwang, Min-Woong
    Bae, Joon-Yong
    Heo, Jun
    Lim, Eun-Joo
    Seok, Won-Seok
    Cheong, Hee Jin
    Song, Joon Young
    Kim, Woo Joo
    Park, Man-Seong
    JOURNAL OF MICROBIOLOGY, 2012, 50 (06) : 1067 - 1070
  • [23] Rapid identification of neuraminidase inhibitor resistance mutations in seasonal influenza virus A(H1N1), A(H1N1)2009, and A(H3N2) subtypes by melting point analysis
    M. Redlberger-Fritz
    S. W. Aberle
    R. Strassl
    T. Popow-Kraupp
    European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31 : 1593 - 1601
  • [24] Efficacy of the New Neuraminidase Inhibitor CS-8958 against H5N1 Influenza Viruses
    Kiso, Maki
    Kubo, Shuku
    Ozawa, Makoto
    Quynh Mai Le
    Nidom, Chairul A.
    Yamashita, Makoto
    Kawaoka, Yoshihiro
    PLOS PATHOGENS, 2010, 6 (02)
  • [25] Neuraminidase inhibitor drug susceptibility differs between influenza N1 and N2 neuraminidase following mutagenesis of two conserved residues
    Ho, Hui-Ting
    Hurt, Aeron C.
    Mosse, Jenny
    Barr, Ian
    ANTIVIRAL RESEARCH, 2007, 76 (03) : 263 - 266
  • [26] Selection of avian influenza A (H9N2) virus with reduced susceptibility to neuraminidase inhibitors oseltamivir and zanamivir
    Kode, Sadhana S.
    Pawar, Shailesh D.
    Cherian, Sarah S.
    Tare, Deeksha S.
    Bhoye, Dipali
    Keng, Sachin S.
    Mullick, Jayati
    VIRUS RESEARCH, 2019, 265 : 122 - 126
  • [27] Multiple Influenza A (H3N2) Mutations Conferring Resistance to Neuraminidase Inhibitors in a Bone Marrow Transplant Recipient
    Eshaghi, Alireza
    Shalhoub, Sarah
    Rosenfeld, Paul
    Li, Aimin
    Higgins, Rachel R.
    Stogios, Peter J.
    Savchenko, Alexei
    Bastien, Nathalie
    Li, Yan
    Rotstein, Coleman
    Gubbaya, Jonathan B.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (12) : 7188 - 7197
  • [28] Reduced susceptibility to all neuraminidase inhibitors of influenza H1N1 viruses with haemagglutinin mutations and mutations in non-conserved residues of the neuraminidase
    McKimm-Breschkin, Jennifer L.
    Williams, Janelle
    Barrett, Susan
    Jachno, Kim
    McDonald, Mandy
    Mohr, Peter G.
    Saito, Takehiko
    Tashiro, Masato
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (10) : 2210 - 2221
  • [29] Reduced sialidase activity of influenza A(H3N2) neuraminidase associated with positively charged amino acid substitutions
    Hussain, Saira
    Daniels, Rodney S.
    Wharton, Stephen A.
    Howell, Steven
    Halai, Chandrika
    Kunzelmann, Simone
    Whittaker, Lynne
    McCauley, John W.
    JOURNAL OF GENERAL VIROLOGY, 2021, 102 (10)
  • [30] Susceptibility of human H3N2 influenza virus to oseltamivir in South Korea, 2009–2011
    Sehee Park
    Jin Il Kim
    Ilseob Lee
    Sangmoo Lee
    Min-Woong Hwang
    Joon-Yong Bae
    Jun Heo
    Eun-Joo Lim
    Won-Seok Seok
    Hee Jin Cheong
    Joon Young Song
    Woo Joo Kim
    Man-Seong Park
    Journal of Microbiology, 2012, 50 : 1067 - 1070